Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders
CA 2442232 A1 · Owner: Lesche, Ralf · Inventors: Lesche, Ralf; Model, Fabian; Lipscher, Evelyne
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to modified and genomic sequences to , oligonucleotides and/or PNA-oligomers for detecting the cytosine methylation state of genomic DNA, as well as to a method for ascertaining genetic and/or epigenetic parameters of genes for use in the differentiation diagnosis, treatment and/or monitoring of hematopoietic cell proliferative disorders or , the predisposition to hematopoietic cell proliferative disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 26, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 26, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 26, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.